Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta-4A chain (TUBB4A) is a structural protein that serves as a fundamental component of microtubules, which are essential for maintaining cellular architecture, facilitating intracellular transport, and enabling chromosome segregation during mitosis. It forms heterodimers with alpha-tubulin, which then polymerize into the hollow tubes that constitute the cytoskeleton. TUBB4A is highly expressed in the central nervous system, particularly in the basal ganglia and cerebellum, where it is critical for the development and maintenance of white matter and myelin. Mutations in the TUBB4A gene are the primary cause of several neurodevelopmental and neurodegenerative disorders, most notably hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) and hereditary whispering dysphonia (DYT4). In the context of oncology, TUBB4A is a target for microtubule-targeting agents (MTAs), including taxanes and vinca alkaloids, which interfere with microtubule dynamics to trigger cell cycle arrest and apoptosis. Furthermore, aberrant expression of TUBB4A has been linked to tumor progression and resistance to chemotherapy in various cancers, such as melanoma and non-small cell lung cancer.
Microtubule-targeting agents bind to specific sites on the beta-tubulin subunit to either stabilize (e.g., taxanes) or destabilize (e.g., vinca alkaloids) microtubules, thereby disrupting the dynamic instability required for mitotic spindle formation and leading to cell cycle arrest and apoptosis.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta-4A chain (TUBB4A) (TUBB4A).